Regulatory News In Brief
This article was originally published in The Tan Sheet
Executive Summary
Far Ocean Group in deep with FDA; Keystone Labs topicals in violation, according to warning letter; NAD nixes Alde’s antifungal nail polish claim; FDA supplement marketing notice e-submissions in the works; South Korea reorganizes, strengthens its Ministry of Food and Drug Safety.
You may also be interested in...
Regulatory News In Brief
Orlistat benefits outweigh risks, EMA says; J&J, Energizer to study SPF 85; Health Canada warns about Miracle Mineral Solution; Regencea recalls RegenArouse; more Regulatory News In Brief
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.